QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 17 March 2021Portfolio NewsAmathus Therapeutics signs strategic collaboration with Merck to Develop Treatments for Neurodegenerative Diseases
- 16 March 2021Portfolio NewsAlchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington’s disease
- 24 February 2021Portfolio NewsXilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective Immuno-Oncology Pipeline
- 11 February 2021Portfolio NewsArtios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients
- 8 February 2021SV NewsThe Annual Healthcare Growth Update
- 8 February 2021Portfolio NewsNordic acquires Bails & Associates
- 3 February 2021Portfolio NewsHealth Payment Systems, Inc. Welcomes SV Health Investors as New Lead Investor
- 2 February 2021Portfolio NewsQurAlis Continues to Expand Leadership Team with Two Key Hires
- 2 February 2021Portfolio NewsAeroCare Announces Completion of Acquisition by AdaptHealth
- 29 January 2021Portfolio NewsCHIME names Bruce Cerullo, Nordic’s Chairman of the Board, a Healthcare Hero
- 26 January 2021Portfolio NewsBicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data of Tumor-Targeted Immune Cell Agonists (TICAs™) in the Journal for ImmunoTherapy of Cancer
- 19 January 2021Portfolio NewsHillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.